Literature DB >> 1487161

Role of ammonia in the pathogenesis of the gastritis, hypergastrinaemia, and hyperpepsinogenaemia I caused by Helicobacter pylori infection.

A M el Nujumi1, P A Rowe, S Dahill, C A Dorrian, W D Neithercut, K E McColl.   

Abstract

Studies were performed in patients with and without renal failure to investigate the role of bacterial ammonia production in the pathogenesis of the mucosal abnormalities caused by Helicobacter pylori. The high rate of H pylori ammonia production in uraemic patients should accentuate any ammonia induced effects. The median (range) gastric juice ammonium concentration in the H pylori positive patients with renal failure was 19 mmol/l (II-43) compared with 5 mmol/l (1-11) in the H pylori positive patients without renal failure (p < 0.005). In the H pylori negative patients the values were 3 mmol/l (0.5-11) and 0.7 mmol/l (0.1-1.4) respectively in the patients with and without renal failure (p < 0.01). Despite the much higher ammonia production in the H pylori positive uraemic patients, the nature and severity of their gastritis was the same as that in the H pylori positive non-uraemic patients. The median (range) fasting serum gastrin concentration was raised in the uraemic patients compared with the non-uraemic patients but was similar in the uraemic patients with (95 pmol/l (52-333)) or without (114 pmol/l (47-533)) H pylori infection. The median (range) serum pepsinogen I concentration was also high in the uraemic compared with the non-uraemic patients and was significantly higher in uraemic patients with H pylori (352 ng/ml, range 280-653) than in those without H pylori infection (165 ng/ml, range 86-337) (p < 0.01). These findings indicate that the gastritis and hypergastrinaemia associated with H pylori infection are not the result of mucosal damage induced by the organism's ammonia production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1487161      PMCID: PMC1379570          DOI: 10.1136/gut.33.12.1612

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Ammonia as a source of gastric hypoacidity in patients with uremia.

Authors:  C S LIEBER; A LEFEVRE
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Cresyl fast violet staining method for Campylobacter like organisms.

Authors:  R A Burnett; I L Brown; J Findlay
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

3.  Urea hydrolysis in patients with Campylobacter pyloridis infection.

Authors:  B J Marshall; S R Langton
Journal:  Lancet       Date:  1986-04-26       Impact factor: 79.321

4.  Serum gastrin in chronic renal failure: its relation to acid secretion, G-cell density, and upper gastrointestinal findings.

Authors:  K Ala-Kaila; M Kekki; I Paronen; T Paakkala
Journal:  Scand J Gastroenterol       Date:  1989-10       Impact factor: 2.423

5.  Intracellular vacuolization caused by the urease of Helicobacter pylori.

Authors:  J K Xu; C S Goodwin; M Cooper; J Robinson
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

6.  Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects.

Authors:  A M el Nujumi; C A Dorrian; R S Chittajallu; W D Neithercut; K E McColl
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

7.  Is Helicobacter pylori associated hypergastrinaemia due to the bacterium's urease activity or the antral gastritis?

Authors:  R S Chittajallu; C A Dorrian; W D Neithercut; S Dahill; K E McColl
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

8.  Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection.

Authors:  D Y Graham; A Opekun; G M Lew; D J Evans; P D Klein; D G Evans
Journal:  Am J Gastroenterol       Date:  1990-04       Impact factor: 10.864

9.  Diet and cell growth modulation by ammonia.

Authors:  W J Visek
Journal:  Am J Clin Nutr       Date:  1978-10       Impact factor: 7.045

Review 10.  Hypothesis: Helicobacter pylori, urease, mucus, and gastric ulcer.

Authors:  R L Sidebotham; J H Baron
Journal:  Lancet       Date:  1990-01-27       Impact factor: 79.321

View more
  7 in total

Review 1.  Personalizing protein nourishment.

Authors:  David C Dallas; Megan R Sanctuary; Yunyao Qu; Shabnam Haghighat Khajavi; Alexandria E Van Zandt; Melissa Dyandra; Steven A Frese; Daniela Barile; J Bruce German
Journal:  Crit Rev Food Sci Nutr       Date:  2017-10-13       Impact factor: 11.176

2.  Effects of Helicobacter pylori infection on gastric epithelial cell kinetics in patients with chronic renal failure.

Authors:  Selim Aydemir; Binnaz Handan Ozdemir; Gurden Gur; Ibrahim Dogan; Ugur Yilmaz; Sedat Boyacioglu
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

3.  Breath ammonia measurement in Helicobacter pylori infection.

Authors:  David J Kearney; Todd Hubbard; David Putnam
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

4.  Effects of excretory/secretory products of Haemonchus contortus on cell vacuolation.

Authors:  Alexandra Huber; Heinrich Prosl; Anja Joachim; Heather V Simpson; Kevin C Pedley
Journal:  Parasitol Res       Date:  2005-05-26       Impact factor: 2.289

5.  Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid.

Authors:  S Banerjee; C Hawksby; S Miller; S Dahill; A D Beattie; K E McColl
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

6.  Cytokine gene expression in Helicobacter pylori associated antral gastritis.

Authors:  S F Moss; S Legon; J Davies; J Calam
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

7.  Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer.

Authors:  Valli De Re; Ombretta Repetto; Stefania Zanussi; Mariateresa Casarotto; Laura Caggiari; Vincenzo Canzonieri; Renato Cannizzaro
Journal:  Infect Agent Cancer       Date:  2017-04-27       Impact factor: 2.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.